Skip to content

Maximus

US · MMS #2545 by market cap Listed 1970
62.79 +0.79 +1.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Fair Value how this is computed

Below fair value
89.83 fair value ≈ 137.84 185.84
  • Implied fair-value range of 89.83-185.84, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -54.4% below the average-multiple fair value of 137.84.

Valuation each multiple against its own 5-year range

P/B ratio 1.95 Cheap vs history 9th percentile
5-year average 2.67 · #19 of 42 in Specialty Business Services
P/E ratio 9.57 Cheap vs history 10th percentile
5-year average 18.96 · forward 9.06 · #2 of 27 in Specialty Business Services
P/S ratio 0.65 Cheap vs history 10th percentile
5-year average 0.89 · forward 0.62 · #15 of 45 in Specialty Business Services

Vs. peers Specialty Business Services

Company Market cap P/E (TTM) P/B Div yield
Maximus (MMS) 3.30B 8.64 1.80 2.05%
Cintas (CTAS) 87.36B 43.39 16.79 0.85%
RELX PLC (RELX) 66.86B 23.66 41.26 2.30%
Thomson Reuters (TRI) 44.02B 28.04 3.92 2.54%
Copart (CPRT) 28.80B 20.06 3.17 0.00%
Global Payments (GPN) 24.30B -19.71 1.05 1.09%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value92.95 Economic moatNone UncertaintyHigh

Trading 48.0% below Morningstar's fair value estimate.

Fair value

On the surface, Maximus Inc appears cheap due to significant downward price pressure over the past year. To incorporate the risk associated with a potential value trap, we have capped its rating at 3 stars. The stock currently trades at a 30% discount to our quantitative fair value estimate of $92.95 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The firm's profitability strengthens our estimated fair value. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. For example, the firm's sales yield of 145.6% ranks in the top 30% globally. This company has a robust ability to generate sales without much capital investment, freeing up more capital to be returned to shareholders in the long run. We believe this is a sign that shares could be cheap.

The firm's valuation metrics are an additional encouraging factor. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to EBITDA ratio of 7.2, for example, ranks in the bottom 30% compared with peers globally. Relative to the company's EBITDA, the enterprise value of the business is low, which further promotes our favorable price/fair value ratio.

Economic moat

With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Maximus discussion 0 comments

Add a comment